Literature DB >> 8460646

BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis.

J S Chamberlain1, M Boehnke, T S Frank, S Kiousis, J Xu, S W Guo, E R Hauser, R A Norum, E A Helmbold, D S Markel.   

Abstract

Previous studies have demonstrated linkage between early-onset breast cancer and ovarian cancer and genetic markers on chromosome 17q21. These markers define the location of a gene (BRCA1) which appears to be inherited as an autosomal dominant susceptibility allele. We analyzed five families with multiple affected individuals for evidence of linkage to the BRCA1 region. Two of the five families appear to be linked to BRCA1. One apparently linked family contains critical recombinants, suggesting that the gene is proximal to the marker D17S579 (Mfd188). These findings are consistent with the maximum-likelihood position estimated by the Breast Cancer Linkage Consortium and with recombination events detected in other linked families. Linkage analysis was greatly aided by PCR-based analysis of paraffin-embedded normal breast tissue from deceased family members, demonstrating the feasibility and importance of this approach. One of the two families with evidence of linkage between breast cancer and genetic markers flanking BRCA1 represents the first such family of African-American descent to be reported in detail.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460646      PMCID: PMC1682065     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Authors:  B Newman; M A Austin; M Lee; M C King
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Allele frequency estimation from data on relatives.

Authors:  M Boehnke
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

3.  Closing in on a breast cancer gene on chromosome 17q.

Authors:  J M Hall; L Friedman; C Guenther; M K Lee; J L Weber; D M Black; M C King
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  Direct construction of a chromosome-specific NotI linking library from flow-sorted chromosomes.

Authors:  M R Wallace; J W Fountain; A M Brereton; F S Collins
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

5.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

6.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

7.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

8.  Family history and the risk of breast cancer.

Authors:  R W Sattin; G L Rubin; L A Webster; C M Huezo; P A Wingo; H W Ory; P M Layde
Journal:  JAMA       Date:  1985-04-05       Impact factor: 56.272

9.  Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.

Authors:  S A Smith; D F Easton; D G Evans; B A Ponder
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  14 in total

1.  Rapid characterization of DNA oligomers and genotyping of single nucleotide polymorphism using nucleotide-specific mass tags.

Authors:  F Abdi; E M Bradbury; N Doggett; X Chen
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Evidence for genetic anticipation in non-Mendelian diseases.

Authors:  A D Paterson; J L Kennedy; A Petronis
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients.

Authors:  Helena Grinberg-Rashi; Samuel Cytron; Zully Gelman-Kohan; Talia Litmanovitch; Lydia Avivi
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 4.  Hereditary breast cancer and family cancer syndromes.

Authors:  H T Lynch; J Lynch; T Conway; P Watson; J Feunteun; G Lenoir; S Narod; R Fitzgibbons
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

5.  THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.

Authors:  A M Bowcock; L A Anderson; L S Friedman; D M Black; S Osborne-Lawrence; S E Rowell; J M Hall; E Solomon; M C King
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

6.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  Medullary thyroid cancer: RET testing of an archival material.

Authors:  Christian Godballe; Gita Jørgensen; Anne-Marie Gerdes; Annelise S Krogdahl; Anne Tybjaerg-Hansen; Finn C Nielsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Authors:  S A Narod; D Ford; P Devilee; R B Barkardottir; H T Lynch; S A Smith; B A Ponder; B L Weber; J E Garber; J M Birch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  BRCA1 testing.

Authors:  Bohdan Górski; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.